| abstract |
Aspects of the present application relate to crystalline and amorphous solid forms of Diroximel fumarate, pharmaceutical compositions and processes thereof. Further, aspects relate to improved processes for the preparation of Diroximel fumarate and intermediates thereof. Specific aspects of the present application provide amorphous solid dispersions of Diroximel fumarate and crystalline Form-DG and Form-DO with Gentisic acid and Oxalic acid, respectively. |